CPL207280
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CPL207280, covering 2023-02-08 to 2023-02-08. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy, Safety and Pharmacokinetics Study of CPL207280 After 2-weeks Administration in Subjects With Type 2 Diabetes [Phase 2]